pubmed-article:7543067 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:7543067 | lifeskim:mentions | umls-concept:C0023434 | lld:lifeskim |
pubmed-article:7543067 | lifeskim:mentions | umls-concept:C0242640 | lld:lifeskim |
pubmed-article:7543067 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
pubmed-article:7543067 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
pubmed-article:7543067 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:7543067 | lifeskim:mentions | umls-concept:C2347946 | lld:lifeskim |
pubmed-article:7543067 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:7543067 | pubmed:dateCreated | 1995-9-5 | lld:pubmed |
pubmed-article:7543067 | pubmed:abstractText | Lymphocytes from patients affected by B-cell chronic lymphocytic leukemia (B-CLL) have frequently been shown to be positive for the multidrug resistance (MDR) phenotype. However, this phenotype does not seem to be responsible for the resistance to alkylating agents usually employed in the management of CLL. | lld:pubmed |
pubmed-article:7543067 | pubmed:language | eng | lld:pubmed |
pubmed-article:7543067 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:7543067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:7543067 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:7543067 | pubmed:issn | 0390-6078 | lld:pubmed |
pubmed-article:7543067 | pubmed:author | pubmed-author:GrassiBB | lld:pubmed |
pubmed-article:7543067 | pubmed:author | pubmed-author:AmbrogiFF | lld:pubmed |
pubmed-article:7543067 | pubmed:author | pubmed-author:PetriniMM | lld:pubmed |
pubmed-article:7543067 | pubmed:author | pubmed-author:TestaJJ | lld:pubmed |
pubmed-article:7543067 | pubmed:author | pubmed-author:CaraccioloFF | lld:pubmed |
pubmed-article:7543067 | pubmed:author | pubmed-author:CapochianiEE | lld:pubmed |
pubmed-article:7543067 | pubmed:author | pubmed-author:Di SimoneDD | lld:pubmed |
pubmed-article:7543067 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:7543067 | pubmed:volume | 80 | lld:pubmed |
pubmed-article:7543067 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:7543067 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:7543067 | pubmed:pagination | 103-7 | lld:pubmed |
pubmed-article:7543067 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:meshHeading | pubmed-meshheading:7543067-... | lld:pubmed |
pubmed-article:7543067 | pubmed:articleTitle | Glutathione-S-transferase activity and multidrug resistance phenotype in chronic lymphocytic leukemia: do they have any clinical relevance? | lld:pubmed |
pubmed-article:7543067 | pubmed:affiliation | Clinica Medica 1, Università di Pisa, Italy. | lld:pubmed |
pubmed-article:7543067 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:7543067 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |